The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2Susanne Krasemann, Ole Pleß, Antje Appelt‐Menzel et al.|Stem Cell Reports|2022Cited by 239
Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous manFrancisco Lopera, Yakeel T. Quiroz, Claudia Mariño et al.|Nature Medicine|2023Cited by 191
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementiaDiego Sepúlveda‐Falla, Yakeel T. Quiroz|Acta Neuropathologica|2022Cited by 89